New Brain Signal Device Enables Cross-Region Synchronous Collection from Thousands; Concept Stocks Surge

Human brain engineering concept stocks traded actively during the session on the 27th. As of press time, Aipeng Medical hit the 20% daily limit up, Beiyikang rose over 17%, Chengdu Huawei Micro rose over 15%, Sanbo Brain and Beiqingsong rose over 10%, and Innovation Medical and Saili Medical also hit the daily limit up.

On the news front, a Chinese research team recently released a new type of brain signal acquisition device, achieving for the first time globally the synchronous collection of brain signals from over a thousand people across different regions. This marks a key step forward in neural large model training and general brain-computer interface technology development.

The brain-computer interface industry is primarily oriented toward the medical and health field, with application demands such as motor function restoration, neural rehabilitation, and assisted treatment of brain diseases continuing to be released. The industry is characterized by technology intensity and interdisciplinary integration, covering multiple links including basic materials, core devices, system integration, and application services, and involving fields such as neuroscience, microelectronics, biomaterials, artificial intelligence, medical devices, and high-end equipment manufacturing. The industry chain can be divided into three main segments: upstream core components, midstream systems and platforms, and downstream application scenarios. Upstream core technology is key to industrial competition, midstream system integration capability determines product competitiveness, and downstream medical and health applications are the main driving force for current industrial development.